awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q24811525-D6EB4035-6A15-46C9-98AC-1DED3CF36A75
Q24811525-D6EB4035-6A15-46C9-98AC-1DED3CF36A75
BestRank
Statement
http://www.wikidata.org/entity/statement/Q24811525-D6EB4035-6A15-46C9-98AC-1DED3CF36A75
Synergistic inhibition of human melanoma proliferation by combination treatment with B-Raf inhibitor BAY43-9006 and mTOR inhibitor Rapamycin
P2860
Q24811525-D6EB4035-6A15-46C9-98AC-1DED3CF36A75
BestRank
Statement
http://www.wikidata.org/entity/statement/Q24811525-D6EB4035-6A15-46C9-98AC-1DED3CF36A75
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
7a3637c17c039e67e91715b6f0d5dd046458cb25
P2860
Phase I clinical and pharmacokinetic study of the Novel Raf kinase and vascular endothelial growth factor receptor inhibitor BAY 43-9006 in patients with advanced refractory solid tumors.